Opinion
Video
Tips for Improving the Interpretation and Reporting of PSMA-PET Imaging Results
Author(s):
Tony Abraham, DO, MPA, outlines the limitations of PSMA-PET imaging and discusses the importance of multidisciplinary care in overcoming challenges surrounding the interpretation and reporting of imaging results.
Video Player is loading.
Video content above is prompted by the following questions:
- In terms of using PSMA-PET imaging in the staging and monitoring of patients with prostate cancer, what are some challenges based on the use of analog vs digital cameras? What are some limitations of older cameras?
- What are some challenges surrounding the interpretation and reporting of PSMA-PET imaging results? Do you have tips for how the entire multidisciplinary care team can work together to ensure everyone is on the same page in terms of reporting/interpreting results and making treatment decisions?
Related Videos
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Neeraj Agarwal, MD, outlines data on enzalutamide plus talazoparib in mCRPC
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
Alicia Morgans, MD, MPH, on PSADT awareness and prostate cancer treatment initiation
Dr Louise Kostos discusses combination therapies in mHSPC
Neeraj Agarwal, MD, on the design of the TALAPRO-2 trial
Related Content
